Cargando…

Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer

Metastatic triple-negative breast cancer (mTNBC) is a heterogeneous disease with a poor prognosis. Individualized survival prediction tool is useful for this population. We constructed the predicted nomograms for breast cancer-specific survival (BCSS) and overall survival (OS) using the data identif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Mao-Shan, Liu, Peng-Cheng, Yi, Jin-Zhi, Xu, Li, He, Tao, Wu, Hao, Yang, Ji-Qiao, Lv, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424305/ https://www.ncbi.nlm.nih.gov/pubmed/36038627 http://dx.doi.org/10.1038/s41598-022-18727-2

Ejemplares similares

A nomogram prediction for the survival of patients with triple negative breast cancer
por: Lin, Yuxiang, et al.
Publicado: (2018)

Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer
por: Yang, Yaping, et al.
Publicado: (2019)

Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age
por: Cui, Xiang, et al.
Publicado: (2021)

Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer
por: Guo, Lin-Wei, et al.
Publicado: (2018)

A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer
por: Meng, Xiangdi, et al.
Publicado: (2023)

Nomogram for predicting overall survival in Chinese triple-negative breast cancer patients after surgery
por: Lin, Wei-Xun, et al.
Publicado: (2022)

Nomogram Personalizes and Visualizes the Overall Survival of Patients with Triple-Negative Breast Cancer Based on the Immune Genome
por: Wang, Peipei, et al.
Publicado: (2020)

Nomogram for Predicting Lymph Node Involvement in Triple-Negative Breast Cancer
por: Cui, Xiang, et al.
Publicado: (2020)

Development and Validation of Nomograms for Predicting the Prognosis of Triple-Negative Breast Cancer Patients Based on 379 Chinese Patients
por: Shi, Hao, et al.
Publicado: (2019)

A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study
por: Zhao, Wen, et al.
Publicado: (2020)

A Nomogram to Predict Disease-Free Survival Following Neoadjuvant Chemotherapy for Triple Negative Breast Cancer
por: Zhu, Meizhen, et al.
Publicado: (2021)

Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer
por: Hsu, Ju-Yi, et al.
Publicado: (2022)

Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer
por: Wang, Jianguo, et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for patients with triple-negative breast cancer with histology of infiltrating duct carcinoma
por: Jing, Na, et al.
Publicado: (2020)

Case report of long-term survival with metastatic triple-negative breast carcinoma: Treatment possibilities for metastatic disease
por: Chue, Ben Man-Fai, et al.
Publicado: (2019)

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Xia, Bingqing, et al.
Publicado: (2021)

Establishment and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients With Early-Stage Triple-Negative Breast Cancer
por: Duan, Fangfang, et al.
Publicado: (2021)

Nomogram for Predicting Overall Survival and Assessing the Survival Benefit of Adjuvant Treatment in pT1-2N0M0 Triple-Negative Breast Cancer: A Surveillance, Epidemiology, and End Results-Based Study
por: Mao, Qixin, et al.
Publicado: (2022)

Development and validation of a nomogram to predict survival in patients with metastatic testicular germ cell tumors
por: Yu, Dong-Dong, et al.
Publicado: (2020)

Survival outcome assessment for triple-negative breast cancer: a nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics
por: Sheng, Dan-li, et al.
Publicado: (2022)

Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis
por: Xu, Yinggang, et al.
Publicado: (2022)

Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China
por: Lin, Shaoyan, et al.
Publicado: (2020)

Development and validation of a nomogram for predicting survival in patients with non-metastatic primary adenocarcinoma of the bladder
por: Yu, Dong-Dong, et al.
Publicado: (2020)

Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer
por: Jiang, Huihong, et al.
Publicado: (2017)

Predicting Survival of De Novo Metastatic Breast Cancer in Asian Women: Systematic Review and Validation Study
por: Miao, Hui, et al.
Publicado: (2014)

Survival Study of Triple-Negative and Non–Triple-Negative Breast Cancer in a Brazilian Cohort
por: Gonçalves, Homero, et al.
Publicado: (2018)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
por: Nandini, Dey, et al.
Publicado: (2021)

Establishment and verification of a nomogram for predicting survival in patients with triple-positive breast cancer
por: Wang, Xingguang, et al.
Publicado: (2022)

Metastatic and triple-negative breast cancer: challenges and treatment options
por: Al-Mahmood, Sumayah, et al.
Publicado: (2018)

Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer
por: Saravia, César H, et al.
Publicado: (2019)

How I treat metastatic triple-negative breast cancer
por: Caparica, Rafael, et al.
Publicado: (2019)

Overview of recent advances in metastatic triple negative breast cancer
por: O'Reilly, David, et al.
Publicado: (2021)

Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
por: Cipriano, Élia, et al.
Publicado: (2021)

Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
por: Heeke, Arielle L., et al.
Publicado: (2021)

Emerging treatment strategies for metastatic triple-negative breast cancer
por: Huppert, Laura A., et al.
Publicado: (2022)

Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc
por: Cui, Jianxiu, et al.
Publicado: (2019)

Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane Treatment
por: li, Meiying, et al.
Publicado: (2015)

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer
por: Deng, G. C., et al.
Publicado: (2021)

Association between obesity with disease-free survival and overall survival in triple-negative breast cancer: A meta-analysis
por: Mei, Lin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4t8tl6e1dcaaggbvqnq9dku9ot